Integrichain Blog


November 17, 2021

Pharma/BioTech GTN Summit


IntegriChain is proud to be a gold sponsor of this year’s GTN summit conference, the foremost and longest-standing event for model-sharing on strategic forecasting, estimates, analytics and reporting for pharmaceutical and biotech companies. 

Our own Jen Sharpe will present welcoming remarks on Day 1, and we hope to connect with you during this virtual event, either at our booth or during our sessions. 

Executive Director, Gross-to-Net

Jen Sharpe
Executive Director, Gross-to-Net

Session: RAC Group Meeting

Date: Wednesday, November 17th 

Time: 2:45 – 4:30 PM EST

Industry participants involved in Government, Commercial, GTN and Trade/Channel Members are invited to this knowledge-sharing session to benchmark and collaborate with industry peers on topics including:

  • Pricing and Contracting
  • Pre-Deal Analytics and Performance Monitoring
  • Rebate and Chargeback Management and Adjudication
  • Government Pricing Reporting and Analytics
  • GTN Channel Forecasting and Scenario Modeling
  • GTN Accrual and Balance Sheet Management, Reporting and Analytics
  • Trade and Channel

Director, Gross to Net - Managed Services

Brittany Honeycutt
Director, Gross to Net - Managed Services

Session: Methodology Showcase and Platform-Centric Strategies for GTN Optimization

Date: Thursday, November 18

Time: 3:15 – 4:00PM EST

This session illustrates current methodologies and company approaches as they relate to prevailing GTN challenges.  And, discover platform-centric strategies that are reshaping the landscape for end-to-end GTN success.  Methodologies explored include:

  • Returns
  • Pipeline
  • Medicaid
  • Coverage Gap

    Executive Director, Gross-to-Net

    Jen Sharpe
    Executive Director, Gross-to-Net

    Session: Corner Office Chat – GTN’s Importance and Materiality into the Broader Business Equation

    Date: Friday, November 19

    Time: 9:00 – 9:30 AM EST

    What you do matters, and is critical to overall organizational success.  This Opening Chat gives a glimpse into the mind of a C-Suite executive and underscores the role of GTN accuracy and proficiency to the broader business.

    • Learn how CEOs articulate the materiality of GTN to external stakeholders
    • Hear visionary insights on future strategy, digitalization and transformation

    Senior Director, Advisory Services

    Angelina Pigna
    Senior Director, Advisory Services

    Session: New Launch Planning and GTN Readiness to Ensure Product Success

    Date: Friday, November 19

    Time: 9:45 – 10:30 AM EST

    Join the conversation as Angelina Pigna moderates a panel with Karyopharm Therapeutics, Gilead Sciences and Collegium Pharmaceutical. 

    • Key areas to look at first for planning GTN accruals and GTN modeling approaches pre-launch
    • Channel management considerations pre-launch
    • Strategies for team collaboration and engaging the right stakeholders
    • Best practices for future forecasting of GTN for product launches
    • Post-launch accrual analysis and adjustments

    For more information on the agenda, and to register for the event, click here.

    adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand